Horace Mann (HMN) CEO sells 5,000 shares at $44.173 via 10b5-1
Horace Mann (HMN) President & CEO and Director Marita Zuraitis reported an open-market sale of 5,000 shares of common stock on 11/03/2025 under a pre-set Rule 10b5-1 trading plan adopted on 11/18/2024.
Rhea-AI Filing Summary
Horace Mann (HMN) President & CEO and Director Marita Zuraitis reported an open-market sale of 5,000 shares of common stock on 11/03/2025 under a pre-set Rule 10b5-1 trading plan adopted on 11/18/2024.
The weighted average sale price was $44.173, with trade prices ranging from $43.83 to $44.39. Following the transaction, she beneficially owns 288,788.422 shares, comprising 212,474.422 vested RSUs and 76,314 common shares. Ownership is reported as direct.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 5,000 | $44.173 | $221K |
Footnotes (3)
- F1. The sale reported in this Form 4 was effected by a Rule 10b5-1 trading plan adopted by the Reporting Person on November 18, 2024.
- F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.83 to $44.39.
- F3. Represents 212,474.422 vested restricted stock units and 76,314 shares of Common Stock.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did HMN's CEO report on Form 4?
Was the HMN trade under a Rule 10b5-1 plan?
What makes up the CEO’s HMN beneficial holdings?
What is the CEO’s relationship to HMN?
AI-generated analysis. How Rhea-AI works. Not financial advice.